Decreased_VBN
concentration_NN
of_IN
1,25-dihydroxyvitamin_NN
D3_NN
receptors_NNS
in_IN
peripheral_JJ
mononuclear_JJ
cells_NNS
of_IN
patients_NNS
with_IN
X-linked_JJ
hypophosphatemic_JJ
rickets_NN
:_:
effect_NN
of_IN
phosphate_NN
supplementation_NN
._.

Abnormal_JJ
renal_JJ
tubular_JJ
phosphate_NN
transport_NN
is_VBZ
considered_VBN
to_TO
be_VB
the_DT
primary_JJ
defect_NN
in_IN
X-linked_JJ
hypophosphatemic_JJ
rickets_NN
-LRB-_-LRB-
XLH_NN
-RRB-_-RRB-
._.

However_RB
,_,
the_DT
resistance_NN
to_TO
vitamin_NN
D_NN
treatment_NN
in_IN
XLH_NN
can_MD
not_RB
be_VB
explained_VBN
by_IN
hypophosphatemia_NN
alone_RB
._.

Since_IN
most_JJS
of_IN
the_DT
actions_NNS
of_IN
vitamin_NN
D_NN
are_VBP
mediated_VBN
by_IN
its_PRP$
receptors_NNS
-LRB-_-LRB-
VDR_NN
-RRB-_-RRB-
,_,
abnormalities_NNS
of_IN
VDR_NN
have_VBP
been_VBN
postulated_VBN
in_IN
XLH_NN
._.

In_IN
order_NN
to_TO
investigate_VB
this_DT
possibility_NN
,_,
we_PRP
measured_VBD
the_DT
concentration_NN
of_IN
VDR_NN
in_IN
PHA-activated_JJ
peripheral_JJ
mononuclear_JJ
cells_NNS
from_IN
10_CD
XLH_NN
patients_NNS
._.

Patients_NNS
without_IN
phosphate_NN
supplementation_NN
showed_VBD
significantly_RB
lower_JJR
concentration_NN
-LRB-_-LRB-
21.7_CD
+_CC
\/_CD
-_:
5.1_CD
fmol\/mg_NN
protein_NN
,_,
mean_NN
+_CC
\/_NN
-_:
SEM_NN
-RRB-_-RRB-
compared_VBN
to_TO
the_DT
normal_JJ
controls_NNS
-LRB-_-LRB-
60.7_CD
+_CC
\/_NN
-_:
4.0_NN
-RRB-_-RRB-
._.

On_IN
the_DT
contrary_NN
,_,
there_EX
was_VBD
no_DT
significant_JJ
difference_NN
between_IN
the_DT
phosphate-supplemented_JJ
patients_NNS
-LRB-_-LRB-
58.3_CD
+_CC
\/_NN
-_:
2.7_NN
-RRB-_-RRB-
and_CC
controls_NNS
._.

There_EX
was_VBD
a_DT
significant_JJ
positive_JJ
correlation_NN
between_IN
VDR_NN
concentration_NN
and_CC
serum_NN
phosphate_NN
-LRB-_-LRB-
P_NN
less_JJR
than_IN
0.05_CD
-RRB-_-RRB-
._.

In_IN
two_CD
patients_NNS
,_,
VDR_NN
was_VBD
increased_VBN
after_IN
daily_JJ
phosphate_NN
supplementation_NN
was_VBD
started_VBN
._.

These_DT
results_NNS
indicate_VBP
that_IN
a_DT
decreased_VBN
concentration_NN
of_IN
VDR_NN
secondary_JJ
to_TO
persistent_JJ
hypophosphatemia_NN
is_VBZ
one_CD
of_IN
the_DT
causes_NNS
of_IN
vitamin_NN
D_NN
resistance_NN
in_IN
XLH_NN
._.

